3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
63
Ovarian Neoplasms
8
Neoplasm Metastasis
8
Endometrial Neoplasms
6
Neoplasms
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Prostatic Neoplasms
4
Hereditary Sensory and Autonomic Neuropathies
4
Carcinoma, Non-Small-Cell Lung
4
Advanced Breast Cancer
4
Squamous Cell Carcinoma of Head and Neck
3
Neoplasms by Site
3
Colorectal Neoplasms
3
Breast Diseases
3
Small Cell Lung Carcinoma
2
Melanoma
2
Locally Advanced (Inoperable) or Metastatic Breast Cancer
2
Head and Neck Neoplasms
2
Uterine Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Unilateral Breast Neoplasms
1
Stomach Neoplasms
1
Spinocerebellar Degenerations
1
Salivary Gland Neoplasms
1
Recurrence
1
Multiple Endocrine Neoplasia Type 1
1
Lung Neoplasms
1
Locoregional Recurrence
1
Interventions
exemestane
2
Tamoxifen
2
Letrozole
2
Anastrozole
2
ribociclib
1
elacestrant
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
abemaciclib
1
Taxes
1
Standard of Care
1
Radiosurgery
1
Psychiatric Rehabilitation
1
Practice Guidelines as Topic
1
Neoadjuvant Therapy
1
Methods
1
Mental Status and Dementia Tests
1
Leuprolide
1
Interviews as Topic
1
Immunotherapy
1
Goserelin
1
Genetic Testing
1
Genetic Counseling
1
Educational Status
1
Early Intervention, Educational
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Neoplasms, Male
×
Fulvestrant
×
90 days
×
Clear all
No trials found.